Close Menu
  • News
  • Stocks
  • Bonds
  • Commodities
  • Collectables
    • Art
    • Classic Cars
    • Whiskey
    • Wine
  • Trading
  • Alternative Investment
  • Markets
  • More
    • Economy
    • Money
    • Business
    • Personal Finance
    • Investing
    • Financial Planning
    • ETFs
    • Equities
    • Funds

Subscribe to Updates

Get the latest markets and assets news and updates directly to your inbox.

Trending Now

‘There’s nothing affordable in the Affordable Care Act’ — and people will likely pay even more in 2027 than 2026. Here’s why.

December 11, 2025

Virginia Museum of Fine Arts Repatriates 2,500-Year-Old Treasures to Turkey

December 11, 2025

Meta’s stock may actually be an overlooked AI winner. Why bulls say to buy the dip.

December 11, 2025
Facebook X (Twitter) Instagram
Facebook X (Twitter) Instagram
The Asset ObserverThe Asset Observer
Newsletter
LIVE MARKET DATA
  • News
  • Stocks
  • Bonds
  • Commodities
  • Collectables
    • Art
    • Classic Cars
    • Whiskey
    • Wine
  • Trading
  • Alternative Investment
  • Markets
  • More
    • Economy
    • Money
    • Business
    • Personal Finance
    • Investing
    • Financial Planning
    • ETFs
    • Equities
    • Funds
The Asset ObserverThe Asset Observer
Home»Stocks
Stocks

Adobe’s AI-driven earnings beat is not enough to boost the stock

Ethan RhodesBy Ethan RhodesDecember 10, 2025
Share
Facebook Twitter LinkedIn Pinterest Email
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

‘There’s nothing affordable in the Affordable Care Act’ — and people will likely pay even more in 2027 than 2026. Here’s why.

Meta’s stock may actually be an overlooked AI winner. Why bulls say to buy the dip.

The bond market is rallying off the Fed’s latest rate cut — but that could change come January

Rivian teases its AI future, but its stock drop shows Wall Street isn’t impressed

Failure of Senate votes on ACA threatens a rise in healthcare costs for everyone

Oracle drags down Nvidia and other AI stocks as bubble fears intensify

Eight stock picks to play one of the healthiest corners of the market

Winklevoss twins thank Trump for his help in wake of Gemini’s disastrous IPO

Eli Lilly’s newest weight-loss drug relieved pain in patients with knee osteoarthritis

Recent Posts
  • ‘There’s nothing affordable in the Affordable Care Act’ — and people will likely pay even more in 2027 than 2026. Here’s why.
  • Virginia Museum of Fine Arts Repatriates 2,500-Year-Old Treasures to Turkey
  • Meta’s stock may actually be an overlooked AI winner. Why bulls say to buy the dip.
  • The bond market is rallying off the Fed’s latest rate cut — but that could change come January
  • Rivian teases its AI future, but its stock drop shows Wall Street isn’t impressed

Subscribe to Newsletter

Get the latest markets and assets news and updates directly to your inbox.

Editors Picks

Virginia Museum of Fine Arts Repatriates 2,500-Year-Old Treasures to Turkey

December 11, 2025

Meta’s stock may actually be an overlooked AI winner. Why bulls say to buy the dip.

December 11, 2025

The bond market is rallying off the Fed’s latest rate cut — but that could change come January

December 11, 2025

Rivian teases its AI future, but its stock drop shows Wall Street isn’t impressed

December 11, 2025

$31.4 million Lalanne Hippopotamus Bar is now most expensive design work ever sold at auction.

December 11, 2025
Facebook X (Twitter) Instagram
© 2025 The Asset Observer. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Press Release
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.